P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 20 August 2014 | 2:30 pm

You are here

Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis® (apixaban) at the ESC Congress 2014 more ...

Published 20 August 2014 | 2:16 pm

Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis® (apixaban) at the ESC Congress 2014

Fourteen abstracts to be presented, including new analyses from the ARISTOTLE more ...

Published 20 August 2014 | 2:16 pm

Bristol-Myers Squibb and Celgene Enter Clinical Collaboration Agreement to Evaluate Immunotherapy and Chemotherapy Combination Regimen

Phase I study to evaluate OPDIVO (nivolumab), Bristol-Myers Squibb's investigational PD-1 immune checkpoint inhibitor, with Celgene's ABRAXANE ® more ...

Published 19 August 2014 | 11:09 pm

FDA Approves Genzyme's CerdelgaTM (eliglustat) Capsules

today that the U.S. Food and Drug Administration (FDA) has approved CerdelgaTM (eliglustat) capsules, the only first-line oral therapy for certain adult Gaucher disease type 1 more ...

Published 19 August 2014 | 10:45 pm

Baxter Announces Hemodialysis Dialyzer Expansion in Opelika, Alabama

Increased Capacity Will Support Growth in End-Stage Renal Disease Therapy more ...

Published 19 August 2014 | 6:31 pm

"Real innovation happens when we are not satisfied with small improvements to the status quo."

Drs. Eirum Chaudhri and Eliav Barr have worked together at Merck for many years in drug discovery. They met recently to discuss innovation and why they find working on more ...

Published 19 August 2014 | 10:27 am

First patients enrolled in study to evaluate dabigatran etexilate after PCI with stenting

* Worldwide RE-DUAL PCITM to enroll up to 8,500 patients with atrial fibrillation who have received a coronary stent1 * Data intended to help understand how to reduce blood more ...

Published 19 August 2014 | 8:17 am

United States Department of Justice closes investigation into PLATO clinical trial for Brilinta

AstraZeneca today announced that it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial with more ...

Published 19 August 2014 | 8:17 am

AstraZeneca announces positive top-line results from the Phase III programme of CAZ-AVI in patients with complicated intra-abdominal infections (cIAI)

CAZ-AVI treated patients with cIAI as effectively as meropenem more ...

Published 19 August 2014 | 12:07 am

Page Error

An error has occurred on the page you are attempting to access. more ...

Pharma Documentation Ring:
22 companies - 5 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Sept. 23-26, 2014, Windsor, UK

Next Annual General Meeting, Sept. 23-26, 2014, Windsor, UK